General Psychiatry - Articles - Page 45

Expert Q&A

ECT: An Update

February 1, 2025

W. Vaughn McCall, MD, MS

Professor Emeritus, Department of Psychiatry and Health Behavior; Medical College of Georgia, Augusta University.

Dr. McCall reports that he is a consultant for Alza TV, Axon Medical Technologies, Carelon, Haleon, and Idorsia. Dr. Aiken has reviewed this educational activity and has determined that there is no commercial bias as a result of this financial relationship.

The FDA has changed the labeling on ECT, and Vaughn McCall clarifies where this treatment fits among newer interventions like ketamine and TMS.

Clinical Update

How Long Should We Continue Esketamine?

February 1, 2025

Steven Hamilton, PhD, MD

Steven Hamilton, MD, PhD. The Permanente Medical Group, Department of Psychiatry, Kaiser Permanente San Francisco Medical Center.

Dr. Hamilton has no financial relationships with companies related to this material.

Response to esketamine (Spravato) is brisk and bold, but how do you keep patients well over the long term? We look at new research on continuation, tapering, and switching strategies.

Temperament and Diagnosis

January 27, 2025

Chris Aiken, MD, Kellie Newsome, PMHNP, and Margaret S. Chisolm, MD

Learn how an understanding of patient’s temperament and the meaning of their life story can unlock psychotherapeutic avenues of treatment on our interview with Margaret Chisolm.

The Missing Perspectives in DSM

January 20, 2025

Chris Aiken, MD, Kellie Newsome, PMHNP, and Margaret S. Chisolm, MD

Margaret Chisolm shares the Perspectives model, a way of assessing patients that builds on the DSM takes the famous manual a few steps further.

2025 Carlat Psychiatry Report Self-Assessment Course

Course Access

January 14, 2025

The 2025 Carlat Psychiatry Report Self-Assessment Course includes all 10 newsletter issues from 2025 and the Hospital Psychiatry Fact Book (2025) for a total of 24 Category 1 CME Credits and 8 ABPN Self-Assessment Credits for Maintenance of Certification.

Psychopharm Secrets: Side Effects

January 13, 2025

Chris Aiken, MD and Kellie Newsome, PMHNP

Depression and cognitive impairment on benzos, tardive dyskinesia, anticholinergics, and neurotoxicity from high dose stimulants. These are the side effects that patients aren’t likely to notice until it’s too late.

Overdiagnosis with Allen Frances

January 6, 2025

Allen Frances, MD, Chris Aiken, MD, and Kellie Newsome, PMHNP

Allen Frances helped create DSM-IV, but in this episode he takes on its diagnostic overreach.

Fact Sheet

Transcranial Magnetic Stimulation (TMS) Fact Sheet on the Inpatient Unit

January 1, 2025

Daniel Carlat, MD and Victoria Hendrick, MD

Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Transcranial Magnetic Stimulation (TMS) is a non-invasive neuromodulation technique primarily used to treat major depressive disorder.

Fact Sheet

Functional Neurological Disorder: Diagnosis and Treatment

January 1, 2025

Daniel Carlat, MD

Dr. Carlat has no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Functional neurological disorder (FND) refers to neurological symptoms that are inconsistent with or cannot be fully explained by medical or neurological conditions.

Fact Sheet